Stem cell treatment in Amyotrophic Lateral Sclerosis

Journal of the Neurological Sciences

Volumn 265, Issue 1-2, 2008, Pages 78-83

  Mazzini, Letizia ^a   Mareschi, Katia ^b   Ferrero, Ivana ^b   Vassallo, Elena ^b   Oliveri, Giuseppe ^c   Nasuelli, Nicola ^a   Oggioni, Gaia Donata ^a   Testa, Lucia ^a   Fagioli, Franca ^b  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

Amyotrophic Lateral Sclerosis; Bone marrow; Mesenchymal stem cells; Motor neuron diseases; Spinal cord; Transplantation

Indexed keywords

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BONE MARROW; CELL COUNT; CELL GROWTH; CELL ISOLATION; CELL PROLIFERATION; CELL THERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOPHENOTYPING; KARYOTYPE; MALE; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; SPINAL CORD; STEM CELL TRANSPLANTATION; TELOMERE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL PROLIFERATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MIDDLE AGED; MOTOR NEURONS; NEURONS; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS;

EID: 37849022487     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2007.05.016     Document Type: Article

References (42)

1. Rowland L.P., and Shneider N.A. Amyotrophic lateral sclerosis. N Engl J Med 344 (2001) 1688-1700
2. Boillé S., Yamanaka K., Lobsiger C., et al. Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312 (2006) 1389-1392
3. Borchelt D.R. Amyotrophic Lateral Sclerosis-are microglia killing motor neurons?. N Engl J Med 12 (2006) 1611-1613
4. Clement A.M., Nguyen E.A., Roberts M.L., et al. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science (2003) 113-117
5. Corti S., Locatelli F., and Donadoni C. Wild-type bone marrow cells ameliorate the phenotype of SOD1-G93A ALS mice and contribute to CNS, heart and skeletal muscle tissues. Brain 127 (2004) 2518-2532
6. Nayak M.S., Kim Y.S., Goldman M., Keirstead H.S., and Kerr D.A. Cellular therapies in motor neuron diseases. Biochim Biophys Acta 1762 (2006) 1128-1138
7. Klein S.M., Behrstock S., McHugh J., et al. GDNF delivery using human neural progenitor cells in a rat model of ALS. Hum Gene Ther 16 4 (2005) 509-521
8. Chi L., Ke Y., Luo C., et al. Motor Neuron Degeneration Promotes Neural Progenitor Cell Proliferation, Migration and Neurogenesis in the Spinal Cords of ALS Mice. Stem Cells 24 (2005) 34-43
9. Pittenger M.F., Mackay A.M., Beck S.C., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
10. Koc O.N., and Lazarus I.I.M. Mesenchymal stem cells: heading into the clinic. Bone Marrow Transplant 27 (2001) 235-239
11. Kim B.J., Seo J.H., Bubien J.K., and Oh Y.S. Differentiation of adult bone marrow stem cells into neuroprogenitor cells in vitro. Neuroreport 13 (2002) 1185-1188
12. Woodbury D., Reynolds K., and Black I.B. Adult bone marrow stromal stem cells express germline, ectodermal, endodermal, and mesodermal genes prior to neurogenesis. J Neurosci Res 69 (2002) 908-917
13. Jiang Y., Jahagirdar B.N., Reinhardt R.L., et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418 (2002) 41-49
14. Lu P., Blesh A., and Tuszynski M.H. Induction of bone marrow stromal cells to neurons: differentiation, transdifferentiation, or artefact?. J Neurosci Res 77 (2004) 174-191
15. Krabbe C., Zimmer J., and Meyer M. Neural transdifferentiation of mesenchymal stem cells-a critical review. APMIS 113 (2005) 831-844
16. + channel types. Exp Hematol 34 11 (2006) 1563-1572
17. Li Y., Chen J., and Wang L. Intracerebral transplantation of bone marrow stromal cells in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. Neurosci Lett 316 (2001) 67-70
18. Akiyama Y., Radtke C., Honmou O., et al. Remyelination of the spinal cord following intravenous delivery of bone marrow cells. Glia 39 (2002) 229-236
19. Crigler L., Robey R.C., Asawachaicharn A., Gaupp D., and Phinney D.G. Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Exp Neurol 198 (2006) 54-64
20. Chopp M., and Li Y. Treatment of neural injury with marrow stromal cells. Lancet Neurol 1 (2002) 92-100
21. Terada N., Hamazaki T., Oka M., et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 416 (2002) 542-545
22. Vercelli A., Garbarossa D., Mereuta M., et al. Transplantation of human mesenchymal stem cells into the lumbar spinal cord of G93A mice. Forum European Neuroscience Vienna (2006)
23. Bae Y.S., Furuya S., and Shinoda Y. Neurodegeneration augments the ability of bone marrow derived mesenchymal stem cells to fuse with Purkinje neurons in Niemann-Pick Type C mice". Hum Gene Ther 16 (2005) 1006-1011
24. Brooks B.R., Miller R.G., Swash M., and Munsat T.L. World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1 (2000) 293-299
25. Butcher J.N., Dahlstrom W.G., Graham J.R., Tellegen A., and Kaemmer B. MMPI-2: Minnesota Multiphasic Personality Inventory: Manual of Administration and Scoring (1989), University of Minnesota Press, Minneapolis
26. The ALS-CNTF treatment Study (ACTS) Phase I-II study group. The Amyotrophic Lateral Sclerosis functional rating scale: assessment of activities of daily living in patients with amyotrophic lateral sclerosis. Arch Neurol 53 (1996) 141-147
27. Norris F.H., Calanchini P.R., Fallat R.J., Panchari S., and Jewett B. The administration of guanidine in amyotrophic lateral sclerosis. Neurology 24 (1974) 721-728
28. Brinkmann J.R., Andres P., Mendoza M., and Sanjak M. Guidelines for the use and performance of quantitative outcome measures in ALS clinical trials. J Neurol Sci 147 (1997) 97-111
29. Magnus T., Beck M., Giess R., Puls I., Naumann M., and Toyka N. Disease progression in amyotrophic lateral sclerosis: predictors of survival. Muscle Nerve 25 (2002) 709-714
30. The Italian ALS study group. Branched-chain aminoacids and ALS: a treatment failure?. Neurology 43 (1993) 2466-2470
31. Kaufmann P., Levy G., Montes J., Buchsbaum R., Barsdorf A.I., Battista V., et al. Excellent inter-rater, intra-rater, and telephone-administered reliability of the ALSFRS-R in a multicenter clinical trial. Amyotroph Lateral Scler Other Motor Neuron Disord 8 1 (Feb 2007) 42-46
32. McNair D.M., Lorr M., and Droppleman L.F. Profile of Mood State Manual (1992), Educational and Industrial Testing Service, San Diego
33. Moons P., Marquet K., Budts W., and De Geest S. Validity, reliability and responsiveness of the Evaluation of Individual Quality of Life - Direct (SEIQoL-DW) in congenital heart disease. Health Qual Life Outcomes 2 (2004) 27
34. Bacigalupo A., Tong J., Podesta M., et al. Bone marrow harvest for marrow transplantation: effect of multiple small (2 ml) or large (20 ml) aspirates. Bone Marrow Transplant 9 (1992) 467-470
35. Mareschi K., Biasin E., Piacibello W., Aglietta M., Madon E., and Fagioli F. Isolation of human mesenchymal stem cells: bone marrow versus umbilical cord blood. Haematologica 86 (2001) 1099-1100
36. Stenderup K., Justesen J., Clausen C., and Kassem M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 33 (2003) 919-926
37. Mareschi K., Ferrero I., Rustichelli D., et al. Expansion of mesenchymal stem cells isolated from pediatric and adult donor bone marrow. J Cell Biochem 97 (2006) 744-754
38. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D., et al. Minimal criteria for defining multipotent mesenchymal stromal cells. Cytotherapy 8 4 (2006) 315-317
39. Ferrero I., Mazzini L., Rustichelli D., Gunetti M., Mareschi K., Testa L., et al. Mesenchymal stem cells from healthy donors and sporadic ALS patients. EHA Scientific Workshop on Biology and Clinical Applications of Mesenchymal Stem Cells, 2006 October 6-8 Cannes, France (2006)
40. Mazzini L., Fagioli F., Boccaletti R., et al. Stem cell therapy in amyotrophic lateral sclerosis: a methodological approach in humans. Amyotroph Lateral Scler Other Motor Neuron Disord 4 (2003) 158-161
41. Mazzini L., Fagioli F., and Boccaletti R. Stem-cell therapy in amyotrophic lateral sclerosis. Lancet 364 (2004) 1936-1937
42. Mazzini L., Mareschi K., Ferrero I., et al. Autologous mesenchymal stem cells: clinical applications in amyotrophic lateral sclerosis. Neurol Res 28 (2006) 523-526